Literature DB >> 26247895

Understanding HIV Care Provider Attitudes Regarding Intentions to Prescribe PrEP.

Amanda D Castel1, Daniel J Feaster, Wenze Tang, Sarah Willis, Heather Jordan, Kira Villamizar, Michael Kharfen, Michael A Kolber, Allan Rodriguez, Lisa R Metsch.   

Abstract

INTRODUCTION: Preexposure prophylaxis (PrEP) is a promising approach to reducing HIV incidence. So, garnering the support of HIV providers, who are most familiar with antiretrovirals and likely to encounter patients in HIV serodiscordant relationships, to scale-up PrEP implementation is essential. We sought to determine whether certain subgroups of HIV providers were more likely to intend to prescribe PrEP.
METHODS: Surveys were administered to HIV providers in Miami, Florida and Washington, District of Columbia. Composite scores were developed to measure PrEP knowledge, experience, and likelihood of prescribing. Latent class analysis was used to stratify provider attitudes toward PrEP.
RESULTS: Among 142 HIV providers, 73.2% had cared for more than 20 HIV-infected patients in the previous 3 months; 17% had ever prescribed PrEP. Latent class analysis identified 2 classes of providers (entropy, 0.904); class 1 (n = 95) found PrEP less effective and perceived barriers to prescribing it; class 2 (n = 47) perceived PrEP as moderately effective and perceived fewer barriers to prescribing it. Compared with class 2, class 1 had significantly less experience with PrEP delivery (t(22.7) = 2.88, P = 0.009) and was significantly less likely to intend to prescribe to patients with multiple sex partners (20% vs. 43%, P = 0.04) and those with a drug use history (7% vs. 24%, P = 0.001).
CONCLUSIONS: Although most HIV providers found PrEP to be effective, those considering it less effective had limited knowledge and experience with PrEP and had lesser intentions to prescribe. Provider training regarding whom should receive PrEP and addressing potential barriers to PrEP provision are needed if this HIV prevention method is to be optimized.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26247895      PMCID: PMC4644475          DOI: 10.1097/QAI.0000000000000780

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  26 in total

1.  Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-01-28       Impact factor: 17.586

2.  Suboptimal awareness and comprehension of published preexposure prophylaxis efficacy results among physicians in Massachusetts.

Authors:  Matthew J Mimiaga; Jaclyn M White; Douglas S Krakower; Katie B Biello; Kenneth H Mayer
Journal:  AIDS Care       Date:  2013-10-14

Review 3.  Pre-exposure prophylaxis for human immunodeficiency virus: the past, present, and future.

Authors:  Amanda D Castel; Manya Magnus; Alan E Greenberg
Journal:  Infect Dis Clin North Am       Date:  2014-11-20       Impact factor: 5.982

4.  Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-08-10       Impact factor: 17.586

5.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

6.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

Review 7.  Engaging healthcare providers to implement HIV pre-exposure prophylaxis.

Authors:  Douglas Krakower; Kenneth H Mayer
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

Review 8.  Emtricitabine/tenofovir disoproxil fumarate: a review of its use in HIV-1 pre-exposure prophylaxis.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

9.  HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study.

Authors:  Douglas Krakower; Norma Ware; Jennifer A Mitty; Kevin Maloney; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2014-09

10.  Attitude towards antiretroviral Pre-Exposure Prophylaxis (PrEP) prescription among HIV specialists.

Authors:  Vincenzo Puro; Antonio Palummieri; Gabriella De Carli; Pierluca Piselli; Giuseppe Ippolito
Journal:  BMC Infect Dis       Date:  2013-05-14       Impact factor: 3.090

View more
  37 in total

1.  HIV-Related Training and Correlates of Knowledge, HIV Screening and Prescribing of nPEP and PrEP Among Primary Care Providers in Southeast United States, 2017.

Authors:  Kirk D Henny; Christopher C Duke; Angelica Geter; Zaneta Gaul; Chantell Frazier; Jennifer Peterson; Kate Buchacz; Madeline Y Sutton
Journal:  AIDS Behav       Date:  2019-11

2.  Effective use of pre-exposure prophylaxis (PrEP) Among stimulant users with multiple condomless sex partners: a longitudinal study of men who have sex with men in Los Angeles.

Authors:  David Goodman-Meza; Matthew R Beymer; Ryan M Kofron; K Rivet Amico; Christina Psaros; Lane R Bushman; Peter L Anderson; Robert Bolan; Wilbert C Jordan; James F Rooney; Amy R Wohl; Raphael J Landovitz
Journal:  AIDS Care       Date:  2019-03-20

3.  Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.

Authors:  E Jennifer Edelman; Brent A Moore; Sarah K Calabrese; Gail Berkenblit; Chinazo Cunningham; Viraj Patel; Karran Phillips; Jeanette M Tetrault; Minesh Shah; David A Fiellin; Oni Blackstock
Journal:  AIDS Behav       Date:  2017-04

4.  HIV Post-Exposure Prophylaxis (PEP) Awareness and Non-Occupational PEP (nPEP) Prescribing History Among U.S. Healthcare Providers.

Authors:  Steven A John; Katherine G Quinn; Benedikt Pleuhs; Jennifer L Walsh; Andrew E Petroll
Journal:  AIDS Behav       Date:  2020-11

5.  Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.

Authors:  Benedikt Pleuhs; Katherine G Quinn; Jennifer L Walsh; Andrew E Petroll; Steven A John
Journal:  AIDS Patient Care STDS       Date:  2020-02-28       Impact factor: 5.078

6.  HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis.

Authors:  Chen Zhang; James McMahon; Kevin Fiscella; Sarahmona Przybyla; Amy Braksmajer; Natalie LeBlanc; Yu Liu
Journal:  AIDS Patient Care STDS       Date:  2019-12       Impact factor: 5.078

7.  A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians.

Authors:  Oni J Blackstock; Brent A Moore; Gail V Berkenblit; Sarah K Calabrese; Chinazo O Cunningham; David A Fiellin; Viraj V Patel; Karran A Phillips; Jeanette M Tetrault; Minesh Shah; E Jennifer Edelman
Journal:  J Gen Intern Med       Date:  2016-10-24       Impact factor: 5.128

8.  Healthcare Access and PrEP Continuation in San Francisco and Miami After the US PrEP Demo Project.

Authors:  Susanne Doblecki-Lewis; Albert Liu; Daniel Feaster; Stephanie E Cohen; Gabriel Cardenas; Oliver Bacon; Erin Andrew; Michael A Kolber
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-15       Impact factor: 3.731

9.  HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.

Authors:  Tanya L Kowalczyk Mullins; Gregory Zimet; Michelle Lally; Jiahong Xu; Sarah Thornton; Jessica A Kahn
Journal:  AIDS Patient Care STDS       Date:  2017-12       Impact factor: 5.078

Review 10.  The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA.

Authors:  Richard Elion; Megan Coleman
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.